Thyroid Medication (Unknown)

Verify with FDA CVM →

388 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
388
Total Reports
16
Deaths Reported
410.0%
Death Rate

Active Ingredients

Thyroid Medication (Unknown)

Administration Routes

OralUnknownAuricular (Otic)TopicalTransdermalIntraocular

Species Affected

Dog 343
Cat 32
Human 10
Unknown 3

Most Affected Breeds

Retriever - Labrador 52
Retriever - Golden 24
Crossbred Canine/dog 18
Domestic Shorthair 16
Spaniel - Cocker American 13
Unknown 13
Terrier - Yorkshire 12
Beagle 12
Chihuahua 11
Boxer (German Boxer) 9

Most Reported Reactions

Emesis 89
Vomiting 75
Lethargy (see also Central nervous system depression in 'Neurological') 42
Lack of efficacy - NOS 40
Lack of efficacy (ectoparasite) - flea 34
Diarrhoea 34
Not eating 19
Behavioural disorder NOS 17
Weight loss 16
Other abnormal test result NOS 16
Decreased appetite 15
Anorexia 14

Outcome Breakdown

Recovered/Normal
176 (45.7%)
Outcome Unknown
110 (28.6%)
Ongoing
50 (13.0%)
Recovered with Sequela
33 (8.6%)
Euthanized
12 (3.1%)
Died
4 (1.0%)

Data Summary

Metric Value
Total adverse event reports 388
Reports involving death 16
Case-fatality rate (reported events) 410.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Thyroid Medication (Unknown) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 388 adverse event reports referencing Thyroid Medication (Unknown), including 16 reports in which the animal died — a 410.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Thyroid Medication (Unknown). Reported administration routes include Oral, Unknown, Auricular (Otic), Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Thyroid Medication (Unknown) reports are Dog (343 reports), Cat (32 reports), Human (10 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (52), Retriever - Golden (24), Crossbred Canine/dog (18) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Thyroid Medication (Unknown) are Emesis (89), Vomiting (75), Lethargy (see also Central nervous system depression in 'Neurological') (42), Lack of efficacy - NOS (40). Of the 385 reports with a coded outcome, Recovered/Normal is the leading category at 45.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Thyroid Medication (Unknown).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial